2016
Hypoxic control of metastasis
Abstract: Metastatic disease is the leading cause of cancer-related deaths and involves critical interactions between tumor cells and the microenvironment. Hypoxia is a potent microenvironmental factor promoting metastatic progression. Clinically, hypoxia and the expression of the hypoxia-inducible transcription factors HIF-1 and HIF-2 are associated with increased distant metastasis and poor survival in a variety of tumor types. Moreover, HIF signaling in malignant cells influences multiple steps within the metastatic …
Search citation statements
Paper Sections
Select...
932
309
190
70
Citation Types
18
1,017
0
2
Year Published
2015
2026
Publication Types
Select...
1,100
186
79
29
Relationship
3
1,391
Authors
Journals
Cited by 1,362 publications
(1,039 citation statements)
References 112 publications
18
1,017
0
2
“…We next assessed PRAK and HIF-1α protein expression using immunohistochemistry in a human tissue array containing 40 lung carcinoma samples with paired lymphatic metastases. Consistent with many other previous reports 6 , 34 – 36 , HIF-1α showed more intensive staining in metastatic than primary tumors (Fig. 6b and d ).…”
Section: Resultssupporting
confidence: 93%
“…We next assessed PRAK and HIF-1α protein expression using immunohistochemistry in a human tissue array containing 40 lung carcinoma samples with paired lymphatic metastases. Consistent with many other previous reports 6 , 34 – 36 , HIF-1α showed more intensive staining in metastatic than primary tumors (Fig. 6b and d ).…”
Section: Resultssupporting
confidence: 93%
“…As several lines of evidence suggest that hypoxia precedes the formation of the EMT state ( Figure 2F, Figure S2I, Figure 3E ), we postulate that these environmental changes contribute to the induction and selection of an epigenetically-stable, pro-metastatic EMT state. This hypothesis aligns with prior reports associating hypoxia with genomic instability and EMT 22,86–88 , including in human lung adenocarcinoma 89 , and here our spatial-lineage data provide new evidence linking subclonal expansion as a mechanism driving hypoxia and tumor progression. In addition to our observation that human lung adenocarcinoma tumors contain spatially-defined hypoxic regions 90 ( Figure S3N-O ), hypoxia has also been shown to play critical roles in lung adenocarcinoma 91 and other cancers (e.g., glioma 92 and clear cell renal cell carcinoma 22 ); thus, further dissecting the relationships between subclonal expansions and hypoxia in these cancers may reveal opportunities for therapies spanning multiple cancer types.…”
Section: Discussionsupporting
confidence: 92%
“…In view of this decline in blood perfusion, it is not surprising that intratumour hypoxia is markedly increased under these conditions ( Figure 5). The aberrant increase in HIF-1a and its target genes, VEGF and CA9, in FSaII tumours observed in response to 15 Gy irradiation ( Figure 6) is in agreement with previous reports that high-dose irradiation induces significant upregulation of HIF-1a in various tumours [31,[35][36][37][38][39][40]43]. In the context of radiation-induced upregulation of HIF-1a, studies to date have shown that hypoxic cells in tumours are reoxygenated after irradiation and HIF-1a is activated in response to the reactive oxygens formed [36].…”
Section: Discussionsupporting
confidence: 92%
